Seppo W. Langer

Denmark

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Anna Sundlöv

Lund University

SWEDEN

View details

Peter Meldgaard

Assistant Professor

Aarhus University

DENMARK

View details

Jesper Krogh

Head of Clinic for Pituitary Disorders

Zealand University Hospital Køge

DENMARK

View details

Bjørn Henning Grønberg

Professor

Norwegian University of Science and Technology

NORWAY

View details

Heidi Søgaard Christensen

Aalborg University

DENMARK

View details

Morten Ladekarl

Aalborg University

DENMARK

View details

Birgitte Bjørnhart

Odense University Hospital

DENMARK

View details

Pernille Holmager

Copenhagen University Hospital

DENMARK

View details

Halla Skuladottir

Clinical Associate Professor

Aarhus University

DENMARK

View details

Claes Nøhr Ladefoged

Technical University of Denmark

DENMARK

View details

Andreas Kjaer

DENMARK

View details

Andreas Carus

Aalborg University

DENMARK

View details

Mikkel Andreassen

DENMARK

View details

René Horsleben Petersen

Københavns Universitet

DENMARK

View details

Nic Gillings

Chief Radiochemist

Copenhagen University Hospital

DENMARK

View details

Barbara Malene Fischer

Professor, senior consultant

Rigshospitalet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Seppo W. Langer

Research Interests

Explore related searches

Contact this professor

Articles (26)

Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC

The Effect of Exercise on Quality of Life in Patients With Advanced Lung Cancer: A Secondary Analysis of a Randomized Controlled Trial

Circulating Tumor DNA and [18F]FDG-PET for Early Response Assessment in Patients with Advanced NSCLC

Recurrence Rates and Patterns after Radical Resection of Lung Carcinoids

NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms

Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177Lu/225AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas

Prognostic thresholds of fluorine-18 fluorodeoxyglucose-positron emission tomography mean and maximum standardized uptake values for survival and nodal involvement in lung neuroendocrine neoplasms

Appendiceal Neuroendocrine Neoplasms

Prognostic Thresholds of Mitotic Count and Ki-67 Labeling Index for Recurrence and Survival in Lung Atypical Carcinoids

Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced Disease

Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020

Clinico-pathological characteristics and treatment outcome in non-small cell lung cancer in Greenland 2015–2020 – a comparison with the cohort from 2004 to 2010

Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center

Recurrence-Free Survival and Disease-Specific Survival in Patients with Pancreatic Neuroendocrine Neoplasms: A Single-Center Retrospective Study of 413 Patients

Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide

Treatment of inoperable large cell neuroendocrine lung cancer with single agent temozolomide

Imaging surveillance in multiple endocrine neoplasia type 1

An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms

Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study

Correction: Christensen et al. Impact of [<sup>18</sup>F]FDG-PET and [<sup>18</sup>F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. <i>Diagnostics</i> 2021, <i>11</i>, 279

Prospective phase II trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT imaging of integrin αvβ3 for prognostication in patients with neuroendocrine neoplasms

Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy

A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms

Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms

First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS)

Collaborators (16)

Anna Sundlöv

Peter Meldgaard

Jesper Krogh

Bjørn Henning Grønberg

Heidi Søgaard Christensen

Morten Ladekarl

Birgitte Bjørnhart

Pernille Holmager

Halla Skuladottir

Claes Nøhr Ladefoged

Andreas Kjaer

Andreas Carus

Mikkel Andreassen

René Horsleben Petersen

Nic Gillings

Barbara Malene Fischer

Make your next move.